Structure

similarity structure
Molecular Formula

C50H67N11O11S2

Molecular Weight 1061.446294 g/mol
SMILES

RUN SEA Predictions

CC(O)C(NC(=O)C1NC(=O)C(C(C)O)NC(=O)C(CCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(NC(=O)C(N)Cc2ccccc2)CSSC1(C)C)C(N)=O  

PubChem|2884

InChI
InChI=1S/C50H67N11O11S2/c1-26(62)39(42(53)65)59-49(72)41-50(3,4)74-73-25-38(58-43(66)33(52)21-28-11-6-5-7-12-28)47(70)56-36(22-29-16-18-31(64)19-17-29)45(68)57-37(23-30-24-54-34-14-9-8-13-32(30)34)46(69)55-35(15-10-20-51)44(67)60-40(27(2)63)48(71)61-41/h5-9,11-14,16-19,24,26-27,33,35-41,54,62-64H,10,15,20-23,25,51-52H2,1-4H3,(H2,53,65)(H,55,69)(H,56,70)(H,57,68)(H,58,66)(H,59,72)(H,60,67)(H,61,71)  
InChIKey
PZWWYAHWHHNCHO-LOWIJWPFNA-N
2D Structure
PubChem|2884

Sequence

Graph alignment
Local alignment
IUPAC Condensed
H-DL-Phe-DL-Cys(1)-DL-Tyr-DL-Trp-DL-Orn-DL-xiThr-DL-Pen(1)-DL-xiThr-NH2  

PubChem|2884

Amino acid chain
H-DL-Phe--DL-Cys(1)--DL-Tyr--DL-Trp--DL-Orn--DL-xiThr--DL-Pen(1)--DL-xiThr-NH2  

CyclicPepedia|PP

Graph representation
H-DL-Phe,DL-Cys,DL-Tyr,DL-Trp,DL-Orn,DL-xiThr,DL-Pen,DL-xiThr-NH2 @1,6  

CyclicPepedia|PP

One letter code from Structure
FCYWATCT  

CyclicPepedia|Struct2seq

Amino acid chain from Structure
Phe--Cys(1)--Tyr--Trp--Orn--Thr--Pen(1)--Eta  

CyclicPepedia|Struct2seq

Description of the conversion sequence The one letter code and Amino acid chain derived from the structural transformation may be inconsistent, with the Amino acid chain containing Essential Amino acid and the one letter code not.
svg Image

PubChem|2884


Chemical and Physical Properties

CyclicPepedia|Struc2Seq + PP

Structure Properties

Property Name Property Value
Exact Mass 1061.446294
Number of Rings 5.0
Complexity 0.77027027
XlogP3 AA -1.2183
Heavy Atom Count 74.0
Hydrogen Bond Donor Count 14.0
Hydrogen Bond Acceptor Count 15.0
Rotatable Bond Count 16.0
Property Name Property Value
Formal Charge 0.0
Refractivity 280.4222
Rule_of_Five 0.0
Number of Atoms 74.0
Topological Polar Surface Area 375.31
Refractivity 280.4222
Veber Rule 0.0
Ghose Filter 0.0

Property Name Property Value
RDKit Fingerprint
11000111110100101111110011110000111101100111100000011011101001101110101110111111111111010100110011110101110101001010011001110111010001011000111100001111000010010101001100111111101111001111000101110100111001001000000110000001010001000101010110001110011101111111010111101110000111101111110000000010000011011111100111010001110100000011111110110110011100000010111100001001100001000010101001101010010100000110000100001110000010110001101000111011110000100000110000010110111000011100000100001110001101000111100100101111111101111110110110001101101010101101100001010110101001100110010010001001000110111100101110010001101010011010100000111111110100111100100111110111011001001110111110111111010111001001011100110001101101101000000111011010101101001111101010110010001110101011100110011000001111001101011010111011001010011011101000001101111011110000011011111101111001110111011100110011010110000111001010000011101101100110111110110110011101110010110001011101101010011011111100110000011001010110001001110011110101000001000000111101111111110111110110111111110101001011000101001110111101100001100001001001110110000111001101001010000011101001100010101101110010010110101000011010101010110100101111001001010011111110011011001000100101011101110011100100011101110111011010011001101111000110101110001010100101111000110100011001011010111101100111110111111001001011111111010000011110110011110010110001111101011111001101000111100101001100100011110101101011001000011001111100100101001011101110101110010101110001110000111111001011010001110100100111111011100101011000010100011111110100110101100000100111100101001011010111000010000011101111101011011010100001010110100010100001100010010010001011001111000110101111100100000010110001111110100100100101000101010110111100100010100011011001011101111010010111100110001000110001111111100011110011111111101100100101110010111110100111111011000001101001110000011011101010010100001101101110010100111111000111011011010111001110010111110110100011111001011101011001001011101101100111010101111100110110011000001011101100010100100100101001111011
Morgan Fingerprint
0101000000100000000000000000000001001000001000000000000000000000100000000000000110000000001000100000000000000000000101010000010010000000000010000001000000000000100000000000000100000000000010000000000000000000000000000000100000010000000000000000100010100000000000000000000000000000001100000100000000000100000000100010000000000100100001000000000000000000000110000000100000000000000000000001010000000000000000000000000000000000000000001001000000000000000000000010000000000000001000100010000000001100000000000000010000000001100000000000000000000000000001000000000010000000000001000010000100000000000000000000000000000000000000000000000000000000000000000010000000000000010001000001000000000001010000000000000000000001000100000000001000100000000000000100000000100001000000000000000000000000001000000000000000001011000010001000100001000000110000000000000001001001010000000100000000000000000000010000010000000000000000000100010000000010000000000000010000000000000001100000001000000000100001000000000000000000000000100100000001010000
MACCS Keys
00000000000000100000000000000000000010000000000000000110000000000111000000100001011110001111100111001100110010111100011011001101000101001111111101110111111111111111110

Sequence Properties

Property Name Property Value
Boman Index -0.55
Instability 17.75
Charge -0.126815546676281
Aliphatic Index 12.5

Binding Target

Detail

Uniprot:  P41143

Kind:  Protein>

Organism:  Homo sapiens(Human)

Evidevce:  TTD

Sequence:  MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA

General Function:

      G-protein coupled receptor

Specific Function:

      G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine.

Additional database information: TTD[Opioid receptor delta (oprd1)]

Other evidence

Property Name Property ID
TTD D0MZ2A
DrugMAP DM7VAJX

Manufacturers

Manufacturers Name Value
CreativePeptides
Bayer healthcare pharmaceuticals
Upsher smith laboratories
Merck
Manufacturers Name Value
Apotex
Baxter Healthcare Corp
Pharmasources
Novartis
AstraZeneca

Information Source

Property Name Property ID
Patents PZWWYAHWHHNCHO-LOWIJWPFNA-N
pubchem 2884
Drugbank
DRAMP3
Uniprot
Cybase
CONOSERVER
BindingDB
CHEMBL
CTD C049352
Wikipedia
KEGG Compound/Drug
CHEBI PZWWYAHWHHNCHO-LOWIJWPFNA-N
EPA DSSTox
FDA Global Substance Registration System (GSRS)
DTP/NCI
Chemspider PZWWYAHWHHNCHO-LOWIJWPFNA-N

Reference

Pubmed_ID Title DOI Journal

2872570

Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors 10.1016/0024-3205(86)90574-6.

Life Sci

Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors

Abstract

  • A series of cyclic conformationally restricted penicillamine containing somatostatin octapeptide analogues have been prepared by standard solid phase synthetic techniques and tested for their ability to inhibit specific 125ICGP 23,996 (des-Ala1-,Gly2-desamino-Cys3Tyr11-dicarba3, 14-somatostatin), 3Hnaloxone or 3HDPDPE (D-Pen2-D-Pen5enkephalin) binding in rat brain membrane preparations. We now report structure-activity relationship studies with the synthesis of our most potent and selective mu opioid receptor compound D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2, which we refer to as Cys2Tyr3Orn5Pen7-amide. While this octapeptide exhibited high affinity (IC50 = 2.80 nM) for an apparently single population of binding sites (nH = 0.89 +/- 0.1) and exceptional selectivity for mu opioid receptors with an IC50(DPDPE)/IC50 (naloxone) ratio of 4,829, it also displayed very low affinity for somatostatin receptors (IC50 = 22,700 nM). Thus, Cys2Tyr3Orn5Pen7-amide may be the ligand of choice for further characterization of mu opioid receptors and for examining the physiological role of this class of receptors.

2893264

H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors

None

NIDA Res Monogr

H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors

Abstract

  • H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) exhibited high affinity (IC50 = 2.80 nM) in displacing 3Hnaloxone binding (nH = 0.89 +/- 0.1) and showed an exceptional selectivity for mu opioid receptors with an IC50(DPDPE)/IC50(naloxone) ratio of 4,840, while it displayed very low affinity for somatostatin receptors (IC50 = 22,700 nM) in rat brain binding assays. 3HCTOP was recently custom synthesized (spec. act.: 84 Ci/mmol) and evaluated for its in vitro binding properties towards the mu opioid receptors in rat brain membrane preparations. Association and dissociation of 3HCTOP binding to mu opioid receptors were rapid at 25 degrees C with a kinetic Kd value of 0.67 nM. Saturation experiments gave apparent Kd value of 1.11 nM and Bmax value of 136 +/- 13 fmol/mg prot at 25 degrees C. Specific 3HCTOP binding was inhibited by a number of different opioid and opiate ligands. Among them, putative mu opioid receptor-specific ligands, such as naloxone, naltrexone and CTOP inhibited the binding with high affinity, while delta opioid receptor-specific compounds or non-opioid drugs inhibited specific 3HCTOP binding with low affinity or they were ineffective.